Toggle Mobile Menu

Explore our impact areas and learn about our grantees.

Early Childhood Development Medical Research & Talent K-12 Education Environmental Innovation Data Science Education Collaborative Philanthropy
Back

Updates

Filter Updates By

All

Collaborative Philanthropy

Data Science Education

Early Childhood Development

Environmental Innovation

K-12 Education

Medical Research & Talent

Valhalla Update

Medical Research & Talent|March 28, 2017

F.D.A. Approves New Drug to Treat Severe Multiple Sclerosis

The drug, ocrelizumab, is one of three new "B-cell" therapies to treat MS that have proven to be extremely effective in preventing MS relapses.